Does Testosterone Therapy Actually Help ED?

Testosterone and Erectile Dysfunction: Separating Evidence from Hype

Few topics in men's health generate as much discussion — and as much misinformation — as the relationship between testosterone and erectile dysfunction. Online forums, social media influencers, and direct-to-consumer hormone clinics have created a narrative that low testosterone is the root cause of most ED and that testosterone replacement therapy (TRT) is the solution.

The clinical reality is more nuanced. Testosterone plays an important but often permissive role in erectile function, and TRT can be highly effective in the right clinical context — but it is rarely a standalone solution for ED. Understanding when testosterone therapy helps, when it doesn't, and when it may be harmful is essential for informed decision-making.

> "Testosterone has become a brand. Men come in asking for TRT the way they might ask for a specific car — they've decided what they want before understanding what they need. My job is to test, evaluate, and recommend based on evidence, not marketing." > — Dr. Lloyd Tapper, PhD, NP — Founder, ReGenesis

The Physiology: How Testosterone Affects Erections

Testosterone influences erectile function through several interconnected mechanisms:

Central Nervous System Effects Testosterone acts on the hypothalamus and limbic system to regulate sexual desire (libido). Low testosterone is strongly associated with reduced sexual interest — which is often the first symptom men notice. Without desire, the neurological cascade that initiates erection is never triggered.

Peripheral Vascular Effects Testosterone upregulates nitric oxide synthase (NOS) — the enzyme that produces nitric oxide (NO) in the endothelium of penile blood vessels. NO is the primary vasodilator responsible for initiating and maintaining erection. Low testosterone reduces NOS expression, decreasing NO availability and impairing vasodilation (Traish et al., 2007, *Journal of Andrology*).

Structural Effects Chronic testosterone deficiency is associated with changes in penile tissue composition — including increased deposition of collagen and adipose tissue in the corpus cavernosum, with corresponding reduction in smooth muscle and elastic fibers (Traish et al., 2009, *American Journal of Men's Health*). These structural changes can impair the veno-occlusive mechanism essential for maintaining erection rigidity.

Mood and Energy Effects Testosterone deficiency is associated with fatigue, depressed mood, irritability, and reduced motivation — all of which indirectly impair sexual function and arousal.

When Is Testosterone Actually Low?

The clinical definition of testosterone deficiency (hypogonadism) is based on both biochemical evidence and clinical symptoms:

Biochemical Thresholds

• Total testosterone < 300 ng/dL (10.4 nmol/L): Generally accepted threshold for hypogonadism by the AUA and EAU
• Total testosterone 300–400 ng/dL: Gray zone — clinical symptoms guide treatment decisions
• Free testosterone: More clinically relevant than total testosterone in some cases, as SHBG levels affect bioavailable testosterone. Low free testosterone with normal total testosterone suggests functionally low androgen status.

Prevalence of Low Testosterone

• Testosterone levels decline approximately 1–2% per year after age 30 (Travison et al., 2007)
• By age 45, approximately 39% of men have total testosterone below 300 ng/dL (Mulligan et al., 2006, *International Journal of Clinical Practice*)
• Obesity, metabolic syndrome, and type 2 diabetes significantly accelerate testosterone decline

> "I test total testosterone, free testosterone, SHBG, estradiol, prolactin, thyroid function, and LH/FSH on every patient. A single total testosterone number without context is clinically insufficient. The pattern matters as much as the number." > — Dr. Lloyd Tapper, PhD, NP

The Evidence: Does TRT Improve ED?

The Testosterone Trials (TTrials)

The most comprehensive evidence comes from the Testosterone Trials — a series of seven coordinated, placebo-controlled studies funded by the National Institutes of Health (NIH) and published in the New England Journal of Medicine (Snyder et al., 2016).

The Sexual Function Trial enrolled 470 men aged 65+ with confirmed low testosterone and sexual dysfunction. Key findings:

• TRT produced a modest but statistically significant improvement in sexual desire and erectile function compared to placebo
• The benefit was most pronounced for sexual desire (libido) and less robust for erectile function specifically
• Approximately 20% of men on TRT achieved clinically meaningful improvement in erectile function beyond placebo response

When TRT Works Best for ED

Research and clinical experience identify specific scenarios where TRT meaningfully improves erectile function:

1. Confirmed hypogonadism (total T < 300 ng/dL) with ED symptoms: Men with truly low testosterone and concurrent ED see the most benefit (Corona et al., 2017, *European Journal of Endocrinology*)
2. PDE5 inhibitor non-responders with low T: Adding testosterone to a PDE5 inhibitor regimen can convert non-responders to responders. A study by Aversa et al. (2003, *Journal of Clinical Endocrinology & Metabolism*) found that testosterone supplementation improved sildenafil efficacy in hypogonadal men who had previously failed oral therapy.
3. Low libido as the predominant symptom: When the primary complaint is reduced desire rather than mechanical erectile failure, TRT addresses the root cause directly

When TRT Doesn't Help ED

• Normal testosterone levels: Men with total testosterone >400 ng/dL and ED are unlikely to benefit from TRT, as the problem lies elsewhere (vascular, neurological, psychological)
• Severe vascular ED: Testosterone cannot overcome advanced atherosclerotic damage — the arterial supply is mechanically insufficient regardless of hormonal status
• Neurogenic ED: Post-surgical or diabetic neuropathy-driven ED requires treatments targeting nerve function, not hormones

Risks and Monitoring Requirements

TRT is not without risks, and responsible prescribing requires ongoing monitoring:

Documented Risks - **Erythrocytosis**: Testosterone stimulates erythropoiesis; hematocrit can rise to dangerous levels (>54%), increasing thrombotic risk. Regular CBC monitoring is mandatory. - **Prostate effects**: TRT does not cause prostate cancer (per current evidence), but it can stimulate growth of existing prostate tissue. PSA monitoring is required. - **Fertility suppression**: Exogenous testosterone suppresses the HPG axis, reducing or eliminating sperm production. This is reversible upon cessation but is critical for men who desire future fertility. - **Cardiovascular risk**: The TRAVERSE trial (Lincoff et al., 2023, *New England Journal of Medicine*) — the largest RCT of TRT to date — found no increased risk of major cardiovascular events, but monitoring remains prudent. - **Sleep apnea exacerbation**: TRT may worsen existing obstructive sleep apnea

Monitoring Protocol at ReGenesis

At our Edmonton and Calgary clinics, TRT monitoring includes:

• Baseline and follow-up blood work at 6 weeks, 3 months, 6 months, then biannually
• Hematocrit and hemoglobin
• PSA
• Lipid panel
• Liver function
• Testosterone levels (trough measurement to confirm therapeutic range)
• Symptom reassessment at each visit

> "Prescribing testosterone without monitoring is negligent. It's a controlled substance with real physiological effects — beneficial when used appropriately, but requiring the same careful supervision as any hormonal therapy." > — Dr. Lloyd Tapper, PhD, NP

Alternatives to TRT for Boosting Testosterone Naturally

For men with borderline testosterone levels (300–450 ng/dL), evidence-based lifestyle interventions can meaningfully increase endogenous production:

• Resistance training: Compound exercises (squats, deadlifts, bench press) acutely and chronically increase testosterone (Vingren et al., 2010, *Sports Medicine*)
• Weight loss: Losing 10% of body weight can increase testosterone by 50–100 ng/dL in obese men (Corona et al., 2013, *European Journal of Endocrinology*)
• Sleep optimization: One week of sleep restriction (5 hours/night) reduced testosterone by 10–15% in young healthy men (Leproult & Van Cauter, 2011, *JAMA*)
• Vitamin D supplementation: Correcting deficiency (<30 ng/mL) is associated with modest testosterone improvement (Pilz et al., 2011, *Hormone and Metabolic Research*)
• Zinc and magnesium: Correcting deficiencies may support testosterone synthesis

The ReGenesis Approach

At our Edmonton and Calgary clinics, testosterone is evaluated as one component of a comprehensive ED assessment — never in isolation. Our protocol:

1. Full hormonal panel — not just total testosterone
2. Identification of reversible causes of low T — obesity, sleep apnea, medications, chronic illness
3. Lifestyle optimization first — where appropriate
4. TRT only when clinically indicated — with informed consent about benefits, risks, and monitoring requirements
5. Combination therapy — TRT + PDE5 inhibitor or other treatments when ED has multiple contributing factors

References

1. Snyder PJ, et al. Effects of testosterone treatment in older men. *New England Journal of Medicine*. 2016;374(7):611-624.
2. Traish AM, et al. Testosterone and erectile function: from basic research to a new clinical paradigm. *Journal of Andrology*. 2007;28(4):490-501.
3. Travison TG, et al. A population-level decline in serum testosterone levels in American men. *Journal of Clinical Endocrinology & Metabolism*. 2007;92(1):196-202.
4. Corona G, et al. Testosterone supplementation and sexual function. *European Journal of Endocrinology*. 2017;178(1):G15-G30.
5. Lincoff AM, et al. Cardiovascular safety of testosterone-replacement therapy. *New England Journal of Medicine*. 2023;389(2):107-117.
6. Mulligan T, et al. Prevalence of hypogonadism in males aged at least 45 years. *International Journal of Clinical Practice*. 2006;60(7):762-769.

Schedule Your Assessment

Confidential assessments available. Same-week appointments for new patients.

Ready to Take the Next Step?

Book a confidential assessment with a ReGenesis clinician.

Call 587.635.3414